View Author
infant leukemia expression patient ara-c flt 3 sample lymphoblastic leukemia resistance study lymphoblastic mutation blood children leukemic level cancer infant mll figure sensitivity childhood leukemic cells treatment group kinase mll gene rearrangement pkc 412 flt 3 expression chapter protein mll gene rearrangements myeloid leukemia mrna expression inhibitor ara-c sensitivity drug resistance receptor infant mll patients nucleoside analysis activation infant mll samples domain myeloid non-infant pieter result value infant mll cells cytotoxicity translocation flt 3 gene transporter mll rearrangements ara-ctp flt 3 inhibition den boer ml factor wild-type inhibition presence difference concentration target sequence enzyme tyrosine gene expression flt 3 mutations mrna expression levels pieters r ara-c cytotoxicity netherland number table outcome activity probe membrane
3 Most Recent Publications
|
Molecular Insights in MLL Rearranged Acute Leukemia
(Doctoral Thesis)
Stam, R.W. |
2006-06-02
|
|
Targeting FLT3 in primary MLL-gene-rearranged infant acute lymphoblastic leukemia
(Article)
Stam, R.W. Sallan, S.E. Valsecchi, M.G. Lorenzo, P. de Pieters, R. Armstrong, S.A. Boer, M.L. den Schneider, P. Nollau, P. Horstmann, M. Beverloo, H.B. Voort, E. van der |
2005-01-01
|
|
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia
(Article)
Stam, R.W. Boer, M.L. den Meijerink, J.P.P. Ebus, M.E. Peters, G.J. Noordhuis, P. Janka-Schaub, G.E. Armstrong, S.A. Korsmeyer, S.J. Pieters, R. |
2003-01-01
|